Survival rates for patients with non-Hodgkin lymphoma have improved since the early 1990s, due partly to the use of rituximab therapy. Medscape Medical News
Methylation of the promoter region of 4 genes from tumor and lymph node cells is associated with greater risk of early recurrence in lung cancer patients. Medscape Medical News
Erythropoiesis-stimulating agents should continue to have an oncology indication, even though questions about their safety remain. Medscape Medical News
A CDC survey shows that overall screening rates for colorectal cancer increased between 2002 and 2006, but the rates vary considerably among states and are still lower among certain minority groups and those without health insurance. Medscape Medical News
